Lingdancao Granules in the Treatment of Seasonal Influenza

Name of study: Randomized, Double-Blinded, Oseltamivir-and-Placebo-Controlled Clinical Study about Lingdancao Granules in the Treatment of Seasonal Influenza Objective: Preliminary evaluation on the efficacy and safety of Lingdancao granules in the treatment of seasonal influenza Design: Multicenter, randomized, double-blind, double parallel analogy, positive drug and placebo controlled trial Case number: This test is expected to be included in 318 cases of 14-65 (≥14 or ≤65) ages of subjects. Qualified participants are randomly divided into experimental drug group (Lingdancao granules group), positive control group (oseltamivir phosphate group) and placebo group, 106 cases in each.